Form D · Other Health Care
Nima Labs, Inc.
San Francisco, CA · CIK 0001590416
Offering snapshot reported May 20, 2016 · SEC filing
- Reported sold
- $9.25M Offering amount: $9.54M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 31, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 20, 2016 | Initial | $9,251,627 | No comparison | 7 | SEC filing |
| Sep 12, 2014 | Initial | $3,999,995 | No comparison | 13 | SEC filing |
| Oct 31, 2013 | Initial | $200,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-263596
Source: Form D, filed May 20, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brad Feld | Director |
| Yves Sisteron | Director |
| Scott Sundvor | Director, Executive |
| Shireen Taleghani | Director, Executive |
| Shireen Yates | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2121 Harrison Street
San Francisco, CA, 94110
San Francisco, CA, 94110